E-LIB Suche - Ergebnisse für: Yee, Megan K

1

Rationale and design of ApoA-I Event Reducing in Ischemic S..:

Gibson, C. Michael ; Kastelein, John J.P. ; Phillips, Adam T....
American Heart Journal. 231 (2021) - p. 121-127 , 2021

2

Longitudinal Assessment of Health Symptoms in Relation to N..:

Yee, Megan K. ; Zundel, Clara G. ; Maule, Alexis L....
Journal of Occupational & Environmental Medicine. 62 (2020) 9 - p. 663-668 , 2020

Link: https://doi.org/10.1097/..

3

Machine learning to predict venous thrombosis in acutely il..:

Nafee, Tarek ; Gibson, C. Michael ; Travis, Ryan...
Research and Practice in Thrombosis and Haemostasis. 4 (2020) 2 - p. 230-237 , 2020

Link: https://doi.org/10.1002/..

4

Relation of White Blood Cell Count to Bleeding and Ischemic..:

Alkhalfan, Fahad ; Nafee, Tarek ; Yee, Megan K....
The American Journal of Cardiology. 125 (2020) 5 - p. 661-669 , 2020

Link: https://doi.org/10.1016/..

5

Most Promising Therapies in Interventional Cardiology:

Kerneis, Mathieu ; Nafee, Tarek ; Yee, Megan K....
Current Cardiology Reports. 21 (2019) 4 - p. , 2019

Link: https://doi.org/10.1007/..

6

Extended prophylaxis of venous thromboembolism with betrixa..:

Ageno, Walter ; Lopes, Renato D. ; Yee, Megan K....
Journal of Thrombosis and Thrombolysis. 49 (2019) 2 - p. 214-219 , 2019

Link: https://doi.org/10.1007/..

7

Net‐clinical benefit of extended prophylaxis of venous thro..:

Ageno, Walter ; Lopes, Renato D. ; Yee, Megan K....
Journal of Thrombosis and Haemostasis. 17 (2019) 12 - p. 2089-2098 , 2019

Link: https://doi.org/10.1111/..

8

Safety and Efficacy of Rivaroxaban When Added to Aspirin Mo..:

Gibson, William J. ; Gibson, C. Michael ; Yee, Megan K....
Journal of the American Heart Association. 8 (2019) 5 - p. , 2019

Link: https://doi.org/10.1161/..

9

Rates of Chronic Medical Conditions in 1991 Gulf War Vetera..:

Zundel, Clara G. ; Krengel, Maxine H. ; Heeren, Timothy...
International Journal of Environmental Research and Public Health. 16 (2019) 6 - p. 949 , 2019

Link: https://doi.org/10.3390/..

10

The CSL112-2001 trial: Safety and tolerability of multiple ..:

Gibson, C. Michael ; Kerneis, Mathieu ; Yee, Megan K....
American Heart Journal. 208 (2019) - p. 81-90 , 2019

Link: https://doi.org/10.1016/..

11

A systematic review of randomized trials comparing double v..:

Sullivan, Alexander E. ; Nanna, Michael G. ; Rao, Sunil V....
Catheterization and Cardiovascular Interventions. 96 (2019) 2 - p. , 2019

Link: https://doi.org/10.1002/..

12

Meta-analysis of self-reported health symptoms in 1990–1991..:

Maule, Alexis L ; Janulewicz, Patricia A ; Sullivan, Kimberly A...
BMJ Open. 8 (2018) 2 - p. e016086 , 2018

Link: https://doi.org/10.1136/..

13

Total bleeding with rivaroxaban versus warfarin in patients..:

Chi, Gerald ; Yee, Megan K. ; Kalayci, Arzu...
Journal of Thrombosis and Thrombolysis. 46 (2018) 3 - p. 346-350 , 2018

Link: https://doi.org/10.1007/..

14

D-Dimer Levels and Effect of Rivaroxaban on Those Levels an..:

AlKhalfan, Fahad ; Kerneis, Mathieu ; Nafee, Tarek...
The American Journal of Cardiology. 122 (2018) 9 - p. 1459-1464 , 2018

Link: https://doi.org/10.1016/..

15

Symptomatic event reduction with extended-duration betrixab..:

Gibson, C. Michael ; Nafee, Tarek ; Yee, Megan K....
American Heart Journal. 198 (2018) - p. 84-90 , 2018

Link: https://doi.org/10.1016/..